Mr. Chopra

Mr. Chopra

Corporate Vice President, Transcatheter Mitral and Tricuspid TherapiesatEdwards Lifesciences· In proxies 2024–2025

Pay in FY2025+26% from the year before

Mr. Chopra was paid $4.7M in FY2025 (Dec), up 26%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Edwards Lifesciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Edwards LifesciencesPublic company · 2 yr
    • Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?